SCHEMBL4921774

SCHEMBL4921774

CC1=C(CCC2(C)CO2)C(C)(C)C(C)CC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8612259 0.74 RARB (0.32) TRPA1
SCHEMBL16052925 0.72 — —
SCHEMBL11824227 0.69 MEN1 (0.30) —
SCHEMBL10362031 0.68 HIF1A (0.30) —
SCHEMBL3259380 0.68 — —
SCHEMBL8609976 0.67 — —
SCHEMBL13517879 0.64 NAMPT (0.31) —
SCHEMBL8634137 0.64 — —
SCHEMBL9493642 0.63 — —
SCHEMBL11467322 0.61 ALDH1A1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214419-A1 Naphthalenone Derivative with Powdery-Ionone Type Odors FIRMENICH SA (CH) 2008-09-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214419-A1 Naphthalenone Derivative with Powdery-Ionone Type Odors IPO5, TRPA1, SCN5A TRPA1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback